1 Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA 2 Department of Epidemiology, Harvard T H ...

Background Cardiovascular disease (CVD) is the leading cause of mortality worldwide, while depression is highly prevalent in this patient population and has long been regarded as an independent risk ...

Results from Asia suggest chronic rhinosinusitis is associated with an increased risk for cancer, but whether these results ...

The Massachusetts Medicaid and Children’s Health Insurance Program launched the Flexible Services Program to address food insecurity through partnerships with social service organizations under its ...

The evolving story of GLP-1 receptor agonists in oncology has yet another new chapter.Several studies presented at San Antonio Breast Cancer Symposium suggested the medications may help extend ...

Can the neurovascular effects of GLP-1s play a role in treating migraine?

By Pooja Toshniwal Paharia A major study of US veterans suggests that GLP-1 diabetes medications may influence addiction-related outcomes, revealing a surprising connection between metabolic ...

Veterans with type 2 diabetes had a higher risk for nonarteritic anterior ischemic optic neuropathy (NAION) after starting semaglutide versus SGLT2 inhibitors. Absolute risk of the potentially ...

People with type 2 diabetes starting semaglutide have more than a doubled risk for nonarteritic anterior ischemic optic neuropathy (NAION) versus those starting sodium-glucose cotransporter-2 ...